RecruitingPhase 4NCT05821972

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine to Induce Preoperative Sedation and Attenuate Emergence Agitation in Children Undergoing Cleft Palate Repair Surgeries

Sponsor

Assiut University

Enrollment

60 participants

Start Date

Apr 10, 2024

Study Type

INTERVENTIONAL

Conditions

Sedation Emergence Delirium

Summary

To compare the efficacy of the pre-operative nebulization of a combination of dexmedetomidine and ketamine versus nebulization of dexmedetomidine alone for sedation and prevention of emergence delirium in children undergoing cleft palate repair surgeries.

Eligibility

Min Age: 12 MonthsMax Age: 48 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Nebulization of dexmedetomidine and a drug called Nebulization of dexmedetomidine and ketamine for people with emergence delirium and sedation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Months to 48 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNebulization of dexmedetomidine and ketamine

Pre-operative nebulization of dexmedetomidine and ketamine

DRUGNebulization of dexmedetomidine

Pre-operative nebulization of dexmedetomidine

Locations(1)

Assiut University

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05821972

Related Trials

Light and Anesthesia

NCT075174841 location

Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU

NCT075965891 location